Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.31
-0.05 (-0.60%)
Nov 16, 2026, 4:00 PM EST - Market closed
ARCT Market Cap
ARCT has a market cap or net worth of $239.52 million as of November 16, 2026. It is the 19,269th most valuable company in the world and the 3,361st biggest in the United States. Its market cap has increased by 15.93% in one year.
Market Cap
239.52M
Enterprise Value
76.56M
1-Year Change
15.93%
Global Rank
Country Rank
#3,361 United States
Category
ChartMarket Cap Chart
Since May 22, 2013, ARCT's market cap has increased from $103.00M to $239.52M, an increase of 132.54%. That is a compound annual growth rate of 6.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 239.50M | 37.49% |
| Dec 31, 2025 | 174.20M | -62.11% |
| Dec 31, 2024 | 459.70M | -45.44% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 138.35% |
| May 22, 2013 | 103.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 255.49M |
| Inovio Pharmaceuticals | 251.50M |
| Q32 Bio | 248.07M |
| Camp4 Therapeutics | 242.23M |
| Rocket Pharmaceuticals | 241.19M |
| Faeth Therapeutics | 239.83M |
| Cabaletta Bio | 239.45M |
| Vanda Pharmaceuticals | 230.39M |